Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of BIOADAPTIVES, INC. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
BIOADAPTIVES, INC. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • BIOADAPTIVES, INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Sep 2025 was $379,502, a 908% decline year-over-year.
  • BIOADAPTIVES, INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was $847,244, a 255% decline from 2019.
  • BIOADAPTIVES, INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2019 was $238,927, a 83% increase from 2018.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

BIOADAPTIVES, INC. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $379,502 -$341,853 -908% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $157,914 +$25,103 +14% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q3 2024 $37,649 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $183,017 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2022 $367,131 +$124,772 +25% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q3 2021 $1,001,089 $34,516 -$21,053 -156% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $980,036 $309,246 +$121,189 +28% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,101,225 $491,903 -$253,981 -107% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $847,244 $165,424 -$68,828 -71% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2021 2020 FY
Q3 2020 $778,416 $13,463 +$41,442 +75% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $819,858 $430,435 -$250,564 -139% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $569,294 $237,922 -$330,367 -357% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $238,927 $96,596 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $54,905 +$593,693 +92% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $179,871 +$232,904 +56% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $92,445 01 Jan 2019 31 Mar 2019 10-Q/A 11 Jun 2020 2020 Q1
Q3 2018 $648,598 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $412,775 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2

BIOADAPTIVES, INC. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2020 $847,244 -$608,317 -255% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2021 2020 FY
2019 $238,927 +$1,167,736 +83% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $1,406,663 01 Jan 2018 31 Dec 2018 10-K/A 12 May 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.